These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 11522612)

  • 21. Enhancement of thrombin- and ionomycin-stimulated prostacyclin and platelet-activating factor production in cultured endothelial cells by a tumor-promoting phorbol ester.
    Zavoico GB; Hrbolich JK; Gimbrone MA; Schafer AI
    J Cell Physiol; 1990 Jun; 143(3):596-605. PubMed ID: 2113537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
    Brkovic A; Sirois MG
    J Cell Biochem; 2007 Feb; 100(3):727-37. PubMed ID: 17115409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of MSK1 in the signaling pathway leading to VEGF-mediated PAF synthesis in endothelial cells.
    Marchand C; Favier J; Sirois MG
    J Cell Biochem; 2006 Aug; 98(5):1095-105. PubMed ID: 16479592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.
    Flamand N; Picard S; Lemieux L; Pouliot M; Bourgoin SG; Borgeat P
    Br J Pharmacol; 2006 Oct; 149(4):385-92. PubMed ID: 16967052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2.
    Gambero A; Thomazzi SM; Cintra AC; Landucci EC; De Nucci G; Antunes E
    Toxicon; 2004 Oct; 44(5):473-81. PubMed ID: 15450921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of phospholipase A2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils.
    Naraba H; Imai Y; Kudo I; Nakagawa Y; Oh-ishi S
    J Biochem; 1995 Aug; 118(2):442-7. PubMed ID: 8543583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis.
    Rechka A; Neagoe PE; Gratton JP; Sirois MG
    Can J Physiol Pharmacol; 2010 Oct; 88(10):968-76. PubMed ID: 20962896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outer-membrane porins from gram-negative bacteria stimulate platelet-activating-factor biosynthesis by cultured human endothelial cells.
    Tufano MA; Biancone L; Rossano F; Capasso C; Baroni A; De Martino A; Iorio EL; Silvestro L; Camussi G
    Eur J Biochem; 1993 Jun; 214(3):685-93. PubMed ID: 8391435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1.
    Thommesen L; Sjursen W; Gåsvik K; Hanssen W; Brekke OL; Skattebøl L; Holmeide AK; Espevik T; Johansen B; Laegreid A
    J Immunol; 1998 Oct; 161(7):3421-30. PubMed ID: 9759860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.
    Heller R; Bussolino F; Calvino R; Ghigo D; Alessio P; Todde R; Fruttero R; Pescarmona G; Gasco A; Till U
    Agents Actions; 1993 Nov; 40(3-4):157-65. PubMed ID: 7517616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.
    Mesri M; Morales-Ruiz M; Ackermann EJ; Bennett CF; Pober JS; Sessa WC; Altieri DC
    Am J Pathol; 2001 May; 158(5):1757-65. PubMed ID: 11337373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
    Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
    Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation.
    Marshall LA; Bolognese B; Roshak A
    Adv Exp Med Biol; 1999; 469():215-9. PubMed ID: 10667333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes.
    Yoshida H; Imaizumi T; Tanji K; Matsumiya T; Sakaki H; Kimura D; Cui XF; Kumagai M; Tamo W; Shibata T; Hatakeyama M; Sato Y; Satoh K
    Brain Res; 2002 Jul; 944(1-2):65-72. PubMed ID: 12106666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labour is associated with increased expression of type-IIA secretory phospholipase A2 but not type-IV cytosolic phospholipase A2 in human myometrium.
    Slater DM; Astle S; Bennett PR; Thornton S
    Mol Hum Reprod; 2004 Nov; 10(11):799-805. PubMed ID: 15361552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism.
    Abid MR; Tsai JC; Spokes KC; Deshpande SS; Irani K; Aird WC
    FASEB J; 2001 Nov; 15(13):2548-50. PubMed ID: 11641265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation.
    Beck S; Lambeau G; Scholz-Pedretti K; Gelb MH; Janssen MJ; Edwards SH; Wilton DC; Pfeilschifter J; Kaszkin M
    J Biol Chem; 2003 Aug; 278(32):29799-812. PubMed ID: 12782627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
    Fleisch JH; Armstrong CT; Roman CR; Mihelich ED; Spaethe SM; Jackson WT; Bobbitt JL; Draheim S; Bach NJ; Dillard RD; Martinelli M; Fouts R; Snyder DW
    J Pharmacol Exp Ther; 1996 Jul; 278(1):252-7. PubMed ID: 8764358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1beta-induced type IIA secreted phospholipase A2 gene expression and extracellular activity in rat vascular endothelial cells.
    Schwemmer M; Aho H; Michel JB
    Tissue Cell; 2001 Jun; 33(3):233-40. PubMed ID: 11469536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.